NCT06653556View on ClinicalTrials.gov

A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2029

Conditions
Systemic Lupus Erythematosus (SLE)
Interventions
BIOLOGICAL

LCAR-AIO T cells

Before treatment with LCAR-AIO T cells, subjects will receive a conditioning regimen.

Trial Locations (1)

Unknown

RECRUITING

Wuhan Union Hospital, Wuhan

Sponsors
All Listed Sponsors
collaborator

Nanjing Legend Biotech Co.

INDUSTRY

collaborator

Beijing GoBroad Hospital

OTHER

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT06653556 - A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter